October 18th, 2007, VANCOUVER BC -->Significant Investments in British Columbia Healthcare Set the Province at the Forefront of Research in HIV/AIDS and Cardiovascular Prevention; Vancouver – Oct. 16, 2007) is seen by LifeSciences BC as a tremendous step forward in enhancing the role of international industry in advancing towards a sustainable healthcare system in British Columbia.
VANCOUVER, Sept. 21 , 2007- On Wednesday September 26, LifeSciences BC is extremely proud to welcome Dr. Bondar to British Columbia for National Biotechnology Week celebrations, in her role as the National Champion for Biotechnology as selected by BIOTECanada.
Vancouver, British Columbia, April 19, 2007 – LifeSciences British Columbia presented $10,000 to the winning teams of the sanofi-aventis Biotech Challenge at its annual BC Biotech Biotechnology Awards Ceremony on Thursday, April 18, 2007.
February 5, 2007, Vancouver, BC -- BC Biotech announces today a name change to LifeSciences British Columbia. The change in name is reflective of an even broader member association and an expanded Life Sciences Industry view beyond biopharmaceuticals. The organization will now begin to extend its advocacy, public policy development and awareness-building activities to ensure all aspects of the bio-economy continues to grow in British Columbia and Canada.
Vancouver, British Columbia -- BC Biotech is pleased to announce that the Federal Government has recently passed new regulations which will strengthen Canadian intellectual property protection for patented medicines, the majority of which are being developed by biotechnology companies, including those in British Columbia.
BC Biotech today announced the appointment of two new board members who represent leading life sciences companies in British Columbia. Peter O’Callaghan, Senior Vice President, Corporate Development and Senior Counsel at QLT Inc., and Dr. Simon Pimstone, Director, and President & Chief Executive Officer at Xenon Pharmaceuticals Inc., were elected to BC Biotech’s Board of Directors at last week’s Annual General Meeting.
Vancouver, British Columbia – Reacting to Premier Gordon Campbell’s announcement to launch a provide-wide Conversation on Healthcare, BC Biotech, the association representing and supporting the biotech community in the province, believes this is a huge step forward in addressing a critical issue to the biotechnology industry in BC – British Columbia’s Healthcare System.
application for marketing and licensing academic research and innovation in Canada, today announces that BC Biotech has chosen Flintbox as the platform to develop a searchable online directory of biotechnologies developed in British Columbia.
BC Biotech presented $10,000 to the winning teams of the sanofi-aventis Biotech Challenge at its annual BC Biotech Biotechnology Awards Ceremony on Thursday, May 5, 2006. This biotech competition for high school students is one of 13 held nationally and is coordinated by BC Biotech in Vancouver.
Vancouver, British Columbia - BC Biotech today announced the recipients of the 2006 BC Biotechnology Awards. These awards are presented annually by BC Biotech to recognize individuals and organizations that have made outstanding contributions to the development of British Columbia’s biotechnology industry, and to increase public awareness and understanding of biotechnology in the province.
FOR IMMEDIATE RELEASE: April 4, 2006 - BC Biotech today announced that Mr. Don Avison, President of the University Presidents’ Council of British Columbia has been appointed to the organization’s Board of Directors.
FOR IMMEDIATE RELEASE: October 3, 2005 - BC Biotech today announced that Dr. Robert Sindelar, Dean of the Faculty of Pharmaceutical Sciences at the University of British Columbia; Mr. Scott Cormack, President and CEO of OncoGenex Technologies; and Mr. Bill Newell, Chief Business Officer of QLT Inc. have been appointed to the organization’s Board of Directors. Mr. Newell will also act as the Vice-Chair of BC Biotech.
Vancouver, British Columbia - BC Biotech today announced the recipients of the 2005 BC Biotechnology Awards. They are: Dr. Anthony Holler, CEO, ID Biomedical for Executive of the Year; Dr. Greg Beatch, Vice President, Scientific Affairs, Cardiome Pharma Corp. for Innovation and Achievement; Aspreva Pharmaceuticals for Life Sciences Company of the Year